Theriva Biologics, Inc. ( TOVX) - Key Metrics
TOVX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.07 | -$0.06 | -$0.06 |
| 2026Q1 | $0.01 | -$0.05 | -$0.06 | -$0.06 |
| 2025Q4 | $0 | -$0.16 | -$0.24 | -$0.24 |
| 2025Q3 | $0 | -$0.45 | -$0.45 | -$0.45 |
| 2025Q2 | $0 | -$1.93 | -$0.70 | -$0.70 |
TOVX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.89 |
| 2026Q1 | 0% | -0.98 |
| 2025Q4 | 0% | -0.54 |
| 2025Q3 | 0% | -0.23 |
| 2025Q2 | 0% | -0.06 |
TOVX
Price: $0.20
52 week price:
Earnings Per Share: 1.44 USD
P/E Ratio: 0.16
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 10.3 million